IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies.
Bergaggio E, Riganti C, Garaffo G, Vitale N, Mereu E, Bandini C, Pellegrino E, Pullano V, Omedè P, Todoerti K, Cascione L, Audrito V, Riccio A, Rossi A, Bertoni F, Deaglio S, Neri A, Palumbo A, Piva R.
Bergaggio E, et al. Among authors: bandini c.
Blood. 2019 Jan 10;133(2):156-167. doi: 10.1182/blood-2018-05-850826. Epub 2018 Nov 19.
Blood. 2019.
PMID: 30455381
Free article.